Position in RCUS
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$30,806,415
-$5,514,244 QoQ
Shares Held
1,426,223
-6.4% QoQ
Ownership
1.13%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 89.53641891906105.ToString("F0")%
Shared 4.629219974716436.ToString("F0")%
None 5.834361106222519.ToString("F0")%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,215,874 across 223 Biotechnology names. RCUS ranks #39 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in RCUS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,806,415 | 1,426,223 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $36,320,659 | 1,524,157 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $20,433,495 | 1,502,463 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $13,511,412 | 1,659,879 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $13,518,349 | 1,722,083 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $25,347,274 | 1,702,302 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $23,301,207 | 1,523,951 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $22,534,718 | 1,479,627 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $30,612,199 | 1,621,409 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $30,457,030 | 1,594,609 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $25,785,442 | 1,436,515 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $23,142,837 | 1,139,480 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $23,841,081 | 1,307,077 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $20,559,846 | 994,190 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $17,791,256 | 680,094 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $8,127,930 | 320,755 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $13,822,301 | 437,969 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $10,013,977 | 247,442 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $1,356,408 | 38,899 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $955,608 | 34,800 | Shares | Defined | 2021-08-12 | |
| 2020-12-31 | $5,159,653 | 198,754 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $5,536,871 | 323,038 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $5,782,826 | 233,744 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $3,256,983 | 234,653 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||